Indian Biotech Firm Avesthagen Closes $32.5M Funding

Filed in archive Corporate and Industrial News by ruth on January 27, 2007

Bangalore-based life sciences company Avestha Gengraine Technologies has closed a $32.5 million round of venture funds from four investors led by Fidelity International, which gained a 10 percent stake for about €10 million ($13 million). Securing this round values the company at Euro 115 million, and makes it the first Indian blue-chip biotech company to achieve milestone in record time of 6 yrs.

The funds will be used to beef up infrastructure, R&D and in the acquisition of technology companies. The company plans to launch its first product in the bio-nutrition segment by late 2007 and its first bio-pharma product in the autoimmune and cardiovascular therapeutic areas by mid-2008.

The company plans to launch its first product in the bio-nutrition segment by late 2007 and its first bio-pharma product in the autoimmune and cardiovascular therapeutic areas by mid-2008. Two cGMP (Current Good Manufacturing Practices) facilities are under construction in Bangalore and Hyderabad.

Avesthagen has also started preparations for its IPO, planned for mid 2008.
Read more from the RedHerring or from the Avethagen press release (pdf).

Related Entries:

Nanomedicine at the Euro Nano Forum 2005 - 07 September 2005
Patenting Human Genes - 17 October 2005
Nanotechnology research funding up, venture capital down - 14 August 2006
Human Embryonic Stem Cell Lines Derived Without Destroying E... - 24 August 2006
Big Biotech Stocks To Perform Better in 2007 - 12 January 2007
Top Biotech Hubs for 2007 - 26 February 2007
Biotech Receives 18% of Angel Investments in 2006 - 22 March 2007
Biotech Still Attract VC Investors - 30 November 2007
2008 Asia Pacific Biotechnology Venture Capital Directory - 04 January 2008

« Topical Eutectic Mixture ... | Main | Brown Algae Polyphenols M... »

Permalink: Indian Biotech Firm Avesthagen Closes $32.5M Funding

Tags: india venture+capital investment biotech funding indian+biotech closes+funding avesthagen+closes

Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/51032

Addthis

Ask

Blinklist

del.icio.us

Digg

Fark

Facebook

Google

Lycos

Ma.gnolia

Mr Wong

Netscape

Netvousz

Newsvine

StumbleUpon

Slashdot

Tailrank

Technorati

Wink

Yahoo

Vote for Indian Biotech Firm Avesthagen Closes $32.5M Funding:

Currently 6.33/10
1
2
3
4
5
6
7
8
9
10

Rating: 6.33 out of 3 vote(s) cast.

Response from: ronnie (02/12/07 12:10pm)

what a great race to finish for this :-- INDIA'S REAL BIOTECHNOLOGY WONDER and a breeding ground of great science.

Add your response to Indian Biotech Firm Avesthagen Closes $32.5M Funding:

Name: *

Email: (will never be shown)*

URL:

(* marked fields are required)

Notify me if more comments appear?

Subscribe to The Biotech Weblog newsletter? (Newsletters are sent out weekly).

Remember me

Security Code: *
(Please help us to sort out spam.)

Please enter your comment here: (Sorry, no HTML is allowed - URLs will be made clickable automatically if you add http:// to your URL.)

We welcome your comments, however all comments are moderated. Offensive or off-topic comments will be deleted and not displayed.

Share It

Use the search to look for other interesting posts

Contributors (Last 90 days)

Shawn Hessinger (1)
Gloria Gamat (5)
Ruth Schaffer (14)
Creative Weblogging (3)

This site has 1333 entries and is powered by Creative Weblogging since July 2005.

Our Editors recommend

Disclaimer

Some of the contents of this site are protected Creative Weblogging Inc. 2004-2010.

Check out our Sponsored Blogs!

Business Computer Blog (UK)

Are you interested in writing a blog in our network?

See which positions are currently open.

Testimonials

'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

'I subscribe to your blog and have been enjoying your posts and perspective.'